Cooper Companies Inc (COO) Receives Average Rating of “Hold” from Brokerages

Cooper Companies Inc (NYSE:COO) has received a consensus rating of “Hold” from the sixteen analysts that are covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $265.40.

Several research analysts recently issued reports on the stock. TheStreet upgraded shares of Cooper Companies from a “c+” rating to a “b-” rating in a research note on Friday, June 15th. ValuEngine upgraded shares of Cooper Companies from a “sell” rating to a “hold” rating in a research note on Friday, June 15th. Oppenheimer set a $265.00 price target on shares of Cooper Companies and gave the stock a “hold” rating in a research note on Friday, June 8th. Raymond James decreased their price target on shares of Cooper Companies from $275.00 to $270.00 and set an “outperform” rating for the company in a research note on Tuesday, June 5th. Finally, Zacks Investment Research lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, May 28th.

Get Cooper Companies alerts:

In other Cooper Companies news, Director Allan E. Rubenstein sold 1,000 shares of the firm’s stock in a transaction dated Friday, June 15th. The shares were sold at an average price of $235.13, for a total transaction of $235,130.00. Following the completion of the sale, the director now directly owns 4,568 shares in the company, valued at approximately $1,074,073.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Daniel G. Mcbride sold 2,147 shares of the firm’s stock in a transaction dated Friday, June 29th. The shares were sold at an average price of $235.13, for a total transaction of $504,824.11. Following the sale, the chief operating officer now owns 28,395 shares of the company’s stock, valued at $6,676,516.35. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,292 shares of company stock valued at $1,220,863. 1.60% of the stock is owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the business. BB&T Investment Services Inc. increased its stake in Cooper Companies by 71.0% during the 4th quarter. BB&T Investment Services Inc. now owns 542 shares of the medical device company’s stock valued at $119,000 after purchasing an additional 225 shares in the last quarter. Verition Fund Management LLC increased its stake in Cooper Companies by 4.2% during the 4th quarter. Verition Fund Management LLC now owns 6,202 shares of the medical device company’s stock valued at $1,351,000 after purchasing an additional 250 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in Cooper Companies by 3.7% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 9,239 shares of the medical device company’s stock valued at $2,114,000 after purchasing an additional 333 shares in the last quarter. First Republic Investment Management Inc. increased its stake in Cooper Companies by 2.0% during the 1st quarter. First Republic Investment Management Inc. now owns 21,614 shares of the medical device company’s stock valued at $4,946,000 after purchasing an additional 434 shares in the last quarter. Finally, IFP Advisors Inc grew its stake in shares of Cooper Companies by 94.0% in the first quarter. IFP Advisors Inc now owns 912 shares of the medical device company’s stock worth $209,000 after acquiring an additional 442 shares during the period. Institutional investors and hedge funds own 96.85% of the company’s stock.

Shares of Cooper Companies stock traded up $1.86 during trading on Tuesday, hitting $238.16. The company’s stock had a trading volume of 281,600 shares, compared to its average volume of 464,199. The company has a debt-to-equity ratio of 0.77, a current ratio of 2.76 and a quick ratio of 1.67. The firm has a market cap of $11.56 billion, a price-to-earnings ratio of 24.55, a PEG ratio of 1.85 and a beta of 0.64. Cooper Companies has a 52 week low of $216.47 and a 52 week high of $260.26.

Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, June 7th. The medical device company reported $2.86 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.84 by $0.02. The company had revenue of $631.30 million during the quarter, compared to analyst estimates of $627.49 million. Cooper Companies had a net margin of 5.58% and a return on equity of 17.14%. Cooper Companies’s quarterly revenue was up 20.8% compared to the same quarter last year. During the same period last year, the business earned $2.50 EPS. equities analysts anticipate that Cooper Companies will post 11.81 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.